logo
Select company
Select metric
$ 55.97MStock Based Compensation
VS
Market
17
Sector
15
Industry
10
History
-
$ 1.73Close
$ 1.7 - $ 5.85 52-Week Range
Ticker Information

Ticker

PPCB

Company Name

PROPANC BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROPANC BIOPHARMA INC - Stock Based Compensation Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PPCB - SB Comp. Historical data
DateStock Based Compensation
6/30/2025$ 55.97M
3/31/2025$ 52.85M
12/31/2024$ 15K
9/30/2024$ 7.5K
6/30/2024$ 0
3/31/2024$ 82.14K
12/31/2023$ 82.14K
9/30/2023$ 138.95K
6/30/2023$ 141.36K
6/30/2022$ 387.14K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Stock Based Compensation

[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].

PPCB - Stock Based Compensation, Last 5 years

$ 0

Minimum

Jun 30, 2024

$ 55.97M

Maximum

Jun 30, 2025

$ 10.97M

Average

$ 110.54K

Median

SB Comp. Benchmark Analysis

The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.15M with a standard deviation of $ 14.38M.
The following table provides additional summary stats:
SB Comp. in the Market:
filtered constituents3.51K
min$ -20.28M
max$ 59.43M
average$ 12.15M
median$ 6.38M
std$ 14.38M